{"@type": "dcat:Dataset", "accessLevel": "public", "bureauCode": ["009:25"], "contactPoint": {"@type": "vcard:Contact", "fn": "NIH/NCBI Data Team", "hasEmail": "mailto:info@ncbi.nlm.nih.gov"}, "description": "The present invention relates to a visceral fat decreasing agent, a visceral fat accumulation inhibitor and a body fat distribution improver, each comprising as an active ingredient a thiazolidine derivative represented by the following formula (IV): <CHEM> wherein A<3> represents an optionally substituted phenyl or oxazolyl group.", "distribution": [{"@type": "dcat:Distribution", "description": "Access the complete Patent AT-E399545-T1: [Translated] AGENTS FOR REDUCING EGG FAT on the official website.", "downloadURL": "https://pubchem.ncbi.nlm.nih.gov/patent/AT-E399545-T1", "mediaType": "text/html", "title": "Official Data Source"}], "identifier": "https://healthdata.gov/api/views/v2fs-znkg", "issued": "2025-09-05", "keyword": ["chemistry", "innovation", "patent", "pubchem", "research"], "landingPage": "https://healthdata.gov/d/v2fs-znkg", "modified": "2025-09-06", "programCode": ["009:066"], "publisher": {"@type": "org:Organization", "name": "National Center for Biotechnology Information (NCBI)"}, "theme": ["NIH"], "title": "Patent AT-E399545-T1: [Translated] AGENTS FOR REDUCING EGG FAT"}